A detailed history of State Board Of Administration Of Florida Retirement System transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 15,072 shares of RCUS stock, worth $236,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,072
Previous 15,072 -0.0%
Holding current value
$236,630
Previous $229,000 0.44%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$14.59 - $18.48 $35,307 - $44,721
-2,420 Reduced 13.83%
15,072 $229,000
Q1 2024

May 08, 2024

BUY
$14.83 - $20.18 $35,888 - $48,835
2,420 Added 16.06%
17,492 $330,000
Q3 2023

Nov 08, 2023

BUY
$17.62 - $23.54 $1,762 - $2,354
100 Added 0.67%
15,072 $270,000
Q2 2023

Aug 11, 2023

SELL
$16.97 - $22.03 $42,764 - $55,515
-2,520 Reduced 14.41%
14,972 $304,000
Q4 2022

Feb 07, 2023

SELL
$19.7 - $35.71 $32,111 - $58,207
-1,630 Reduced 8.52%
17,492 $362,000
Q2 2022

Aug 05, 2022

BUY
$17.23 - $37.73 $37,044 - $81,119
2,150 Added 12.67%
19,122 $485,000
Q1 2022

May 06, 2022

SELL
$28.92 - $41.83 $78,951 - $114,195
-2,730 Reduced 13.86%
16,972 $536,000
Q4 2021

Feb 08, 2022

SELL
$31.38 - $48.47 $58,806 - $90,832
-1,874 Reduced 8.69%
19,702 $797,000
Q2 2021

Aug 10, 2021

BUY
$22.75 - $35.77 $180,316 - $283,513
7,926 Added 58.07%
21,576 $592,000
Q1 2021

May 10, 2021

BUY
$26.16 - $41.39 $3,924 - $6,208
150 Added 1.11%
13,650 $383,000
Q4 2020

Feb 08, 2021

BUY
$17.0 - $32.36 $13,430 - $25,564
790 Added 6.22%
13,500 $350,000
Q3 2020

Nov 09, 2020

BUY
$17.14 - $25.47 $11,483 - $17,064
670 Added 5.56%
12,710 $218,000
Q2 2020

Aug 07, 2020

BUY
$13.97 - $36.56 $8,745 - $22,886
626 Added 5.48%
12,040 $298,000
Q1 2020

May 05, 2020

BUY
$8.78 - $19.28 $100,214 - $220,061
11,414 New
11,414 $158,000

Others Institutions Holding RCUS

About Arcus Biosciences, Inc.


  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.13B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.